lnza-20240228
0001843724false00018437242024-02-282024-02-280001843724us-gaap:CommonStockMember2024-02-282024-02-280001843724us-gaap:WarrantMember2024-02-282024-02-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 28, 2024
LanzaTech Global, Inc.
(Exact name of registrant as specified in its charter)
Delaware001-4028292-2018969
(State or other jurisdiction
of incorporation)
(Commission File Number)(I.R.S. Employer
Identification No.)
8045 Lamon Avenue, Suite 400
Skokie, Illinois
60077
(Address of principal executive offices)(Zip Code)
(847) 324-2400
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolsName of each exchange on which registered
Common Stock, par value $0.0001 per shareLNZA
The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50LNZAW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02. Results of Operations and Financial Condition.
On February 28, 2024, LanzaTech Global, Inc. (Nasdaq: LNZA), issued a press release announcing its financial results for the fiscal year ended December 31, 2023.
In connection with issuing the press release, LanzaTech Global, Inc. will host a conference call on Wednesday February 28, 2023 to discuss its financial results for its fiscal year ended December 31, 2023. In connection therewith, LanzaTech Global, Inc. is providing an earnings presentation to stockholders, analysts, and any other parties participating on the call. Copies of the Company’s press release and earnings presentation are attached as Exhibits 99.1 and 99.2 to this Form 8-K and incorporated herein by reference.
The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2 furnished herewith, is being furnished and shall not be deemed “filed” for any purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such Section. The information in this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of certain Officers; Compensatory Arrangement of Certain Officers.
Appointment of Aura Cuellar as President
On February 27, 2024, the Company appointed Aura Cuellar to serve as the Company’s President, effective March 1, 2024. Ms. Cuellar has served as the Company’s Executive Vice President of Growth and Strategic Projects since May 2023. Prior to joining LanzaTech, Ms. Cuellar served as Vice President of Energy Transition for Shell plc in the United States from July 2021 to April 2023. During her 24-year tenure at Shell, Ms. Cuellar held various senior executive global roles including Head of Projects and Turnarounds in The Netherlands from July 2016 to December 2019. Ms. Cuellar’s compensation arrangement has not been modified in connection with her appointment as President at this time.
There are no arrangements or understandings between Ms. Cuellar and any other persons pursuant to which she was appointed as the President of the Company. There are no family relationships between Ms. Cuellar and the executive officers or directors of the Company, and no transactions involving the Company and Ms. Cuellar that would be required to be reported pursuant to Item 404(a) of Regulation S-K.
Departure of Carl Wolf as Chief Operating Officer
On February 27, 2024, the Company and Carl Wolf agreed that Mr. Wolf would step down from his position as Chief Operating Officer of the Company in April 2024. In connection with Mr. Wolf’s departure from the Company, he will be entitled to severance pursuant to his Executive Employment Agreement as if he was terminated without cause.
Forward-looking Statements
This Current Report on Form 8-K includes forward-looking statements regarding, among other things, the plans, strategies and prospects, both business and financial, of LanzaTech. These statements are based on the beliefs and assumptions of LanzaTech’s management. Although LanzaTech believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, LanzaTech cannot assure you that it will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or similar expressions. The forward-looking statements are based on projections prepared by, and are the responsibility of, LanzaTech’s management. These forward-looking statements are not guarantees of future
2


performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside LanzaTech’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. LanzaTech may be adversely affected by other economic, business, or competitive factors, and other risks and uncertainties, including those described under the header “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2022 filed by LanzaTech with the SEC, and in future SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2023 to be filed by LanzaTech with the SEC on or before February 29, 2024. New risk factors that may affect actual results or outcomes emerge from time to time and it is not possible to predict all such risk factors, nor can LanzaTech assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements attributable to LanzaTech or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. LanzaTech undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Item 9.01. Financial Statements and Exhibits.
(d)    Exhibits
Exhibit NumberDescription
99.1
99.2
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
3


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 28, 2024
LANZATECH GLOBAL, INC.
By:/s/ Joseph Blasko
Name:Joseph Blasko
Title:General Counsel and Corporate Secretary
4
a4q23fy23lnzaearningsrel
LanzaTech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Outlook Total revenue of $20.5 million for fourth quarter 2023, increase of 77% over fourth quarter 2022 Full year 2024 revenue anticipated to be between $90 million and $105 million with Adjusted EBITDA for the full year 2024 of between $(65) million and $(55) million Cash, restricted cash, and investments of $121.4 million at year-end 2023, with lower quarterly cash burn of $15.4 million for fourth quarter 2023 CHICAGO, IL (February 28, 2024) – LanzaTech Global, Inc. (Nasdaq: LNZA) (“LanzaTech” or the “Company”), the carbon recycling company transforming waste carbon into sustainable raw materials, today reported its financial and operating results for the fourth quarter and full year 2023. Fourth Quarter and Full Year 2023 Financial Results: In the fourth quarter of 2023, revenue totaled $20.5 million, reflecting an increase of 77% compared to $11.6 million in the fourth quarter of 2022. Financial and operating results in the quarter reflect continued growth, primarily in our core Biorefining, carbon capture and utilization business which grew 103% year- on-year in the fourth quarter, fueled by ongoing and recently initiated engineering services work across several projects. Our CarbonSmart and JDA & Contract Research businesses grew 253% and 5% year-over- year, respectively during the fourth quarter. For the full year 2023, revenue totaled $62.6 million, reflecting an increase of 68% compared to $37.3 million for the prior year. Cost of revenues in the fourth quarter totaled $12.0 million, driving gross profit of $8.5 million, which reflects a gross profit increase of 238% over the prior corresponding period. Gross margin improved to 41% during the fourth quarter, reflecting certain engineering services work completed during the quarter which benefited from extraordinary pricing terms. For full year 2023, cost of revenues totaled $45.0 million, resulting in gross profit of $17.7 million, an increase of 95% compared to $9.1 million for the prior year, as a beneficial shift in revenue mix towards higher margin, engineering services and royalty revenues enabled revenue growth to meaningfully outpace the rate of growth in associated cost of revenues. Operating expenses totaled $27.1 million in the fourth quarter, up 24% year-on-year, but down 9% from the prior quarter, reflecting lower research and development and SG&A expenses during the quarter as well as greater billable utilization of the Company’s teams. For the full year 2023, operating expenses totaled $124.0 million, reflecting an increase of 47% compared to $84.7 million for the prior year, driven largely by higher selling, general and administrative expenses associated with the Company’s transition to a public company completed in February 2023 as well as higher research and development expenses.


 
Net loss totaled $(18.7) million for the fourth quarter 2023, compared to a net loss of $(21.4) million in the fourth quarter of 2022, bringing full year 2023 net loss to $(134.1) million, compared to a full year 2022 net loss of $(76.4) million. Adjusted EBITDA for the fourth quarter was $(13.7) million, reflecting a sequential improvement of 28% compared to the third quarter of 2023, and driving full year 2023, Adjusted EBITDA of $(80.1) million. The positive trend in Adjusted EBITDA over the course of 2023 is largely attributable to the robust top line growth, particularly in the Biorefining business, and continued operating expense control across the business. Management Commentary "2023 was an important year for LanzaTech, and I am extremely proud of the many notable milestones and accomplishments achieved during the Company’s inaugural year as a publicly traded company,” said Jennifer Holmgren, Board Chair and Chief Executive Officer of LanzaTech. “However, our results for the fourth quarter and full year 2023 demonstrate we have a lot more work ahead of us. The organizational initiatives and corrective actions announced are focused on better enabling us to execute our primary strategic objectives including safety, commercial growth, and profitability. While I am disappointed in our financial performance in the fourth quarter, after three prior quarters of more significant growth, I have full confidence in our leadership team to execute our business plan and to continue our path toward profitability with a new sense of accountability from the top down.” Organizational Streamlining Initiative LanzaTech announced today a reorganization aimed at reducing operating expenses and driving accountability and company-wide efficiencies. As part of this effort, LanzaTech has made several organizational changes to its management team, which reduces the overall size of the go-forward executive team by 33%. The goal of this reorganization is to drive greater accountability, as well as operational transparency and efficiency, ultimately enhancing execution throughout the Company. In addition to the reorganization of the management team, the Company also announced additional cost reductions. A key tenet of this plan is the streamlining of the Company’s workforce through the elimination of a variety of roles based on reprioritization of work and poor performance. As such, the Company reduced its headcount by approximately 5%. The collective impact of the workforce reorganization and reductions includes an estimated $5.3 million reduction in annualized operating expenses, and $4.2 million in annualized cash savings. Additionally, the Company also announced an 80% reduction in the targeted size of the 2023 cash bonus payouts for the executive and management teams. Management is also implementing a plan to offset over $10 million in additional cash burn annually and will continuously review the organization and its strategic growth initiatives to ensure the Company is balancing the need to drive sustainable, profitable growth and innovation. Operational Highlights • 3 New Commercial Scale Plants Started Up in 2023 – In 2023, together with its licensee partners, the Company started up three new commercial-scale plants, bringing the total number of operating commercial LanzaTech plants to six. The total installed nameplate production capacity across the operating fleet is approximately 310,000 tons per year of ethanol with the ability to abate more than 500,000 tons per year of carbon that would otherwise enter our atmosphere.


 
• World’s First Ethanol-to-Sustainable Aviation Fuel Facility – In January 2024, LanzaJet celebrated the opening of the world’s first ethanol-to-sustainable aviation fuel facility at its 10 million gallon per year facility in Soperton, Georgia. The sustainable aviation fuel plant is expected to ramp up production over the first half of the year, having the ability to produce up to 90% sustainable aviation fuel and 10% renewable diesel. LanzaTech retains an approximate 25% ownership interest in LanzaJet and anticipates receiving additional shares pursuant to our existing agreements resulting in ownership of approximately 50%, barring further dilution, upon election by partners and co-investors to develop additional alcohol to sustainable aviation fuel plants. • Research and Development Progress on New Bacterium Strains – Work at the Suncor demonstration facility in Canada progressed and the Company demonstrated at scale the ability to produce a key new proprietary bacterium production strain capable of making Isopropyl Alcohol, or IPA. IPA commands a large market of approximately $3 billion annually and can be utilized as a feedstock for the production of polypropylene, which has an annual market size of approximately $123 billion. Additionally, strain engineering and fermentation optimization work on the direct microbial production of Monoethylene Glycol, or MEG, a chemical with an annual market size of approximately $25 billion, and a key ingredient in PET fibers and bottles, continues with encouraging results. Balance Sheet and Liquidity As of December 31, 2023, LanzaTech had $121.4 million in total cash, restricted cash, and investments compared to $136.9 million at the end of the third quarter 2023. Cash burn during the fourth quarter 2023 was $(15.4) million, continuing the trend over 2023 of reducing quarterly cash burn. The Company expects to see ongoing improvements in cash burn quarter over quarter as the business continues to expand and cost control measures recently announced begin to drive material results. 2024 Financial and Operating Outlook For the full year 2024, the Company expects total revenue to be between $90 million and $105 million and Adjusted EBITDA for the full year 2024 to be between $(65) million and $(55) million. The anticipated growth in our top-line revenue, compared to $62.6 million of revenue reported for full year 2023, is projected to be driven by contributions from each of the business lines. Biorefining revenue growth is anticipated to be driven by ongoing and new engineering services revenue, while JDA & Contract Research revenue is expected to continue at a modest pace of growth in 2024. The CarbonSmart business is expected to deliver incremental growth in 2024. Consistent with this guidance, the Company does not expect to achieve positive Adjusted EBITDA by the end of 2024. Importantly, the Company’s project pipeline remains robust. The delay in timing to first achieve positive Adjusted EBITDA is driven by an elongation of the project development life cycle, commensurate with certain macroeconomic factors and lengthier decision-making processes being seen at some of the Company’s prospective licensee customers. The Company will continue to assess its progress towards this important goal and provide updates to the market, as necessary. Conference Call Information


 
LanzaTech will host a conference call today, February 28, 2024, at 8:30 A.M. EDT to review the Company's financial results, discuss recent events and conduct a question-and-answer session. The conference call may be accessed via a live webcast on a listen-only basis at https://ir.lanzatech.com/news- events/events-presentations. To participate in the live teleconference: Domestic callers: 1-844-826-3035 International callers: 1-412-317-5195 Conference ID: 10185471 A replay will be available shortly after the call and can be accessed by dialing: Domestic callers: 1-844-512-2921 International callers: 1-412-317-6671 Access ID: 10185471 The replay will be available until 11:59 PM EDT March 13, 2024. An archive of the webcast will be available shortly after the call on LanzaTech’s website at https://ir.lanzatech.com/ for twelve months following the call. About LanzaTech Global Inc. LanzaTech Global, Inc. (NASDAQ: LNZA) is the carbon recycling company transforming waste carbon into sustainable raw materials for everyday products. Using its biorecycling technology, LanzaTech captures carbon generated by energy-intensive industries at the source, preventing it from being emitted into the air. LanzaTech then gives that captured carbon a new life as a clean replacement for virgin fossil carbon in everything from household cleaners and clothing fibers to packaging and fuels. By partnering with companies across the global supply chain like ArcelorMittal, Zara, H&M Move, Coty, and On, LanzaTech is paving the way for a circular carbon economy. For more information about LanzaTech, visit https://lanzatech.com. Forward Looking Statements This press release includes forward-looking statements regarding, among other things, the plans, strategies and prospects, both business and financial, of LanzaTech. These statements are based on the beliefs and assumptions of LanzaTech’s management. Although LanzaTech believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, LanzaTech cannot assure you that it will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These


 
statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or similar expressions. The forward-looking statements are based on projections prepared by, and are the responsibility of, LanzaTech’s management. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside LanzaTech’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward- looking statements. LanzaTech may be adversely affected by other economic, business, or competitive factors, and other risks and uncertainties, including those described under the header “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2022 filed by LanzaTech with the SEC, and in future SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2023 to be filed by LanzaTech with the SEC on or before February 29, 2024. New risk factors that may affect actual results or outcomes emerge from time to time and it is not possible to predict all such risk factors, nor can LanzaTech assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward- looking statements attributable to LanzaTech or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. LanzaTech undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Non-GAAP Financial Measures To supplement our financial statements presented in accordance with US GAAP and to provide investors with additional information regarding our financial results, we have presented adjusted EBITDA, a non- GAAP financial measure. Adjusted EBITDA is not based on any standardized methodology prescribed by US GAAP and is not necessarily comparable to similarly titled measures presented by other companies. We define adjusted EBITDA as our net loss, excluding the impact of depreciation, interest income, net, stock-based compensation, change in fair value of warrant liabilities, change in fair value of SAFE liabilities, change in fair value of the FPA Put Option liability and Fixed Maturity Consideration, transaction costs on issuance of Forward Purchase Agreement, (loss) gain from equity method investees and other one-time costs related to the Business Combination and securities registration on Form S-4 and our registration statement on Form S-1. We monitor and have presented in this Annual Report adjusted EBITDA because it is a key measure used by our management and the Board to understand and evaluate our operating performance, to establish budgets, and to develop operational goals for managing our business. We believe adjusted EBITDA helps identify underlying trends in our business that could otherwise be masked by the effect of certain expenses that we include in net loss. Accordingly, we believe adjusted EBITDA provides useful information to investors, analysts, and others in understanding and evaluating our operating results and enhancing the overall understanding of our past performance and future prospects. Adjusted EBITDA is not prepared in accordance with US GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with US GAAP. There are a number of


 
limitations related to the use of adjusted EBITDA rather than net loss, which is the most directly comparable financial measure calculated and presented in accordance with US GAAP. For example, adjusted EBITDA: (i) excludes stock-based compensation expense because it is a significant non-cash expense that is not directly related to our operating performance; (ii) excludes depreciation expense and, although this is a non-cash expense, the assets being depreciated and amortized may have to be replaced in the future; (iii) excludes gain or losses on equity method investee; and (iv) excludes certain income or expense items that do not provide a comparable measure of our business performance. In addition, the expenses and other items that we exclude in our calculations of adjusted EBITDA may differ from the expenses and other items, if any, that other companies may exclude from adjusted EBITDA when they report their operating results. In addition, other companies may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.


 
LANZATECH GLOBAL INC. CONSOLIDATED BALANCE SHEETS (In thousands of U.S. dollars, except share and per share data) As of December 31, 2023 December 31, 2022 Assets Current assets: Cash and cash equivalents $ 75,585 $ 83,045 Held-to-maturity investment securities 45,159 - Trade and other receivables, net of allowance 11,157 11,695 Contract assets 28,238 18,000 Other current assets 12,561 11,157 Total current assets 172,700 123,897 Property, plant and equipment, net 22,823 19,689 Right-of-use assets 18,309 6,969 Equity method investment 7,066 10,561 Equity security investment 14,990 14,990 Other non-current assets 5,736 750 Total assets $ 241,624 $ 176,856 Liabilities, Contingently Redeemable Preferred Stock, and Shareholders’ Deficit Current liabilities: Accounts payable $ 4,060 $ 7,455 Other accrued liabilities 7,316 4,502 AM SAFE liability - 28,986 Warrants 7,614 4,108 Contract liabilities 3,198 3,101 Accrued salaries and wages 5,468 7,031 Current lease liabilities 126 798 Total current liabilities 27,782 55,981 Non-current lease liabilities 19,816 6,615 Non-current contract liabilities 8,233 10,760 Fixed maturity consideration 7,228 - FPA Put Option liability 37,523 - Brookfield SAFE liability 25,150 50,000 Other long-term liabilities 1,421 1,591 Total liabilities 127,153 124,947 Contingently Redeemable Preferred Stock Redeemable convertible preferred stock, $0.0001 par value; 20,000,000 and 130,133,670 shares authorized, — and 129,148,393 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively - 480,631


 
Shareholders’ Deficit Common stock, $0.0001 par value; 400,000,000 and 158,918,093 shares authorized, 196,642,451 and 10,422,051 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively 19 1 Additional paid-in capital 943,960 24,782 Accumulated other comprehensive income 2,364 2,740 Accumulated deficit (831,872) (456,245) Total shareholders’ equity (deficit) $ 114,471 $ (428,722) Total liabilities, contingently redeemable preferred stock, and shareholders' equity $ 241,624 $ 176,856 See the accompanying Notes to the Consolidated Financial Statements. LANZATECH GLOBAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands of U.S. dollars, except share and per share data) Year Ended December 31, 2023 2022 Revenue: Revenue from contracts with customers and grants $ 46,493 $ 27,798 Revenue from sales of CarbonSmart products 5,337 4,000 Revenue from collaborative arrangements 4,989 2,575 Revenue from related party transactions 5,812 2,970 Total revenue 62,631 37,343 Cost and operating expenses: Cost of revenue from contracts with customers and grants (exclusive of depreciation shown below) (37,653) (22,912) Cost of revenue from sales of CarbonSmart products (exclusive of depreciation shown below) (4,889) (3,648) Cost of revenue from collaborative arrangements (exclusive of depreciation shown below) (2,265) (1,250) Cost of revenue from related party transactions (exclusive of depreciation shown below) (172) (477) Research and development expense (68,142) (53,191) Depreciation expense (5,452) (4,660) Selling, general and administrative expense (50,438) (26,804) Total cost and operating expenses (169,011) (112,942) Loss from operations (106,380) (75,599) Other income (expense): Interest income, net 4,572 8 Other expense, net (29,388) (2,757)


 
Total other expense, net (24,816) (2,749) Loss before income taxes (131,196) (78,348) Income tax expense - - (Loss) gain from equity method investees, net (2,902) 1,992 Net loss $ (134,098) $ (76,356) Other comprehensive loss: Foreign currency translation adjustments (376) (1,449) Comprehensive loss $ (134,474) $ (77,805) Unpaid cumulative dividends on preferred stock (4,117) (38,672) Net loss allocated to common shareholders $ (138,215) $ (115,028) Net loss per common share - basic and diluted $ (0.79) $ (12.37) Weighted-average number of common shares outstanding - basic and diluted 176,023,219 9,302,080 See the accompanying Notes to the Consolidated Financial Statements. LANZATECH GLOBAL INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands of U.S. dollars) Year Ended December 31, 2023 2022 Cash Flows From Operating Activities: Net loss $ (134,098) $ (76,356) Adjustments to reconcile net loss to net cash used in operating activities: - - Share-based compensation expense 15,199 2,527 (Gain) loss on change in fair value of SAFE and warrant liabilities (14,471) 1,949 Loss on change in fair value of the FPA Put Option and the Fixed Maturity Consideration liabilities 44,300 - Provision for losses on trade and other receivables 700 - Depreciation of property, plant and equipment 5,452 4,660 Amortization of discount on debt security investment (1,301) - Non-cash lease expense 1,526 1,825 Non-cash recognition of licensing revenue (1,805) (2,160) Loss (gain) from equity method investees, net 2,902 (1,992) Gain from disposal of property, plant and equipment - (49) Net foreign exchange loss (gain) 182 668 Changes in operating assets and liabilities: Accounts receivable, net 104 (8,817)


 
Contract assets (10,049) (6,246) Accrued interest on debt investment (266) - Other assets (2,658) (5,127) Accounts payable and accrued salaries and wages (4,991) 8,243 Contract liabilities 95 (488) Operating lease liabilities (337) (2,028) Other liabilities 2,220 (1,312) Net cash used in operating activities $ (97,296) $ (84,703) Cash Flows From Investing Activities: Purchase of property, plant and equipment (8,553) (10,735) Proceeds from disposal of property, plant and equipment - 49 Purchase of debt securities (93,858) - Proceeds from maturity of debt securities 50,000 - Purchase of additional interest in equity method investment (288) - Origination of related party loan (5,212) - Net cash used in investing activities $ (57,911) $ (10,686) Cash Flows From Financing Activities: Proceeds from issue of equity instruments of the Company - 1,194 Proceeds from the Business Combination and PIPE, net of transaction expenses (Note 3) 213,381 - Forward Purchase Agreement prepayment (60,096) - Proceeds from exercise of options 2,550 - Proceeds from issue of SAFE and warrant instruments - 50,000 Repurchase of equity instruments of the Company (7,650) (649) Net cash provided by financing activities $ 148,185 $ 50,545 Net increase (decrease) in cash, cash equivalents and restricted cash (7,022) (44,844) Cash, cash equivalents and restricted cash at beginning of period 83,710 128,732 Effects of currency translation on cash, cash equivalents and restricted cash (404) (178) Cash, cash equivalents and restricted cash at end of period $ 76,284 $ 83,710 Supplemental disclosure of non-cash investing and financing activities: Acquisition of property, plant and equipment under accounts payable 279 246 Receipt of common shares as payment for option exercises - 1,944 Right-of-use asset additions 12,866 4,108 Reclassification of capitalized costs related to the business combination to equity 1,514 - Cashless conversion of warrants on preferred shares 5,890 - Recognition of public and private warrant liabilities in the Business Combination 4,624 - Reclassification of AM SAFE warrant to equity 1,800 - Conversion of AM SAFE liability into common stock 29,730 - Conversion of Legacy LanzaTech NZ, Inc. preferred stock and in-kind dividend into common stock 722,160 - Reclassification of Shortfall warrant to equity 3,063 -


 
See the accompanying Notes to the Consolidated Financial Statements. Reconciliation of GAAP Net Income to Adjusted EBITDA (In thousands of U.S. dollars) Year Ended December 31, 2023 2022 Net Loss $ (134,098) $ (76,356) Depreciation 5,452 4,660 Interest income, net (4,572) (8) Income tax expense - - Stock-based compensation expense and change in fair value of SAFE and warrant liabilities (1) 728 4,476 Change in fair value of the FPA Put Option and Fixed Maturity Consideration liabilities 44,300 - Transaction costs on issuance of Forward Purchase Agreement 451 - Loss (gain) from equity method investees, net 2,902 (1,992) One-time costs related to the Business Combination and initial securities registration(2) 4,693 - Adjusted EBITDA $ (80,144) $ (69,220) (1) Stock-based compensation expense represents expense related to equity compensation plans (2) Represents costs incurred related to the Business Combination that do not meet the direct and incremental criteria per SEC Staff Accounting Bulletin Topic 5.A to be charged against the gross proceeds of the transaction, but are not expected to recur in the future, as well as costs incurred subsequent to deal close related to our securities registration on Form S-4 and our registration statement on Form S-1.


 
# # # Contacts: Media Relations Contact - LanzaTech Kit McDonnell Director of Communications press@lanzatech.com Investor Relations Contact - LanzaTech Omar El-Sharkawy VP, Corporate Development LanzatechIR@icrinc.com


 
a4q2023earningspresentat
4Q AND FY 2023 EARNINGS PRESENTATION February 28, 2024 Nasdaq: LNZA A Carbon Recycling Company ©2024 LanzaTech Inc. All rights reserved.


 
These slides and any accompanying oral presentation contain forward-looking statements. All statements, other than statements of historical fact, included in these slides and any accompanying oral presentation are forward-looking statements reflecting management’s current beliefs and expectations. In some cases, you can identify forward-looking statements by terminology such as “will,” “anticipate,” “expect,” “believe,” “intend” and “should” or the negative of these terms or other comparable terminology. Forward-looking statements in these slides and any accompanying oral presentation include, but are not limited to, statements about estimates and forecasts of other financial and performance metrics and projections of market opportunity, expectations and timing related to the rollout of our business and timing of deployments, customer growth and other business milestones. These statements are based on various assumptions, whether or not identified in this presentation, and on the current expectations of our management and are not predictions of actual performance. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. The potential risks and uncertainties that could cause actual results to differ from the results predicted include, among others, those risks and uncertainties included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-Q filed with the Securities and Exchange Commission and subsequent annual reports, quarterly reports and other filings made with the Securities and Exchange Commission from time to time. Any forward- looking statements contained herein are based on assumptions that we believe to be reasonable as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future. Forward-looking statements may include, for example, statements about: • our anticipated growth rate and market opportunities; • our ability to maintain the listing of our securities on the Nasdaq Stock Market; • the potential liquidity and trading of our securities; • our ability to raise financing in the future; • our assessment of the competitive landscape; • our ability to comply with laws and regulations applicable to our business; • our ability to enter into, successfully maintain and manage relationships with industry partners; • our receipt of substantial additional financing to fund our operations and complete the development and commercialization of our process technologies; • the availability of governmental programs designed to incentivize the production and consumption of low-carbon fuels and carbon capture and utilization; • our ability to adequately protect our intellectual property rights; • our ability to attract, retain and motivate qualified personnel and to manage our growth effectively; • our future financial performance and capital requirements; • our ability to implement and maintain effective internal controls; and • the impact of the COVID-19 pandemic on our business. This presentation includes data obtained from third-party studies and internal company surveys prepared for other purposes. The company has not independently verified the data obtained from these sources. Forward-looking information obtained from these sources is subject to the same qualification and the additional uncertainties regarding the other forward-looking statements in this presentation. This presentation contains trademarks, service marks, trade names, and copyrights of ours and of other companies, which are the property of their respective owners. The use or display of third parties’ trademarks, service marks, trade name or products in this presentation is not intended to, and does not imply, a relationship with us, or an endorsement or sponsorship by or of LanzaTech. Solely for convenience, the trademarks, service marks and trade names referred to in this presentation may appear with the TM or SM symbols, but such references are not intended to indicate, in any way, that LanzaTech will not assert, to the fullest extent permitted under applicable law, their rights or the right of the applicable licensor to these trademarks, service marks and trade names. SAFE HARBOR STATEMENT 2


 
3 Biorefining: CCT Plants AGENDA / TABLE OF CONTENTS Sections Presenter • 2023 Recap. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Jennifer Holmgren, CEO • 2024 Strategic Priorities. . . . . . . . . . . . . . . . . . . . . . . . Jennifer Holmgren, CEO • 4Q 2023 & FY 2023 Financial Results. . . . . . . . . . . . . .Geoff Trukenbrod, CFO • 2024 Financial Guidance Summary. . . . . . . . . . . . . . . Geoff Trukenbrod, CFO • Appendix: Additional Financial Information • Appendix: Executive Team Biographies Nasdaq: LNZA


 
2023 RECAP Nasdaq: LNZA


 
2023 FINANCIAL RECAP $100$ millions 2023 REVENUE 2023 ADJUSTED EBITDA $ millions ($75) • 2023 revenue increased 68% YoY to $62.6 million • Strong quarterly revenue growth through 9M 2023, but weaker than expected 4Q 2023 caused miss vs. guidance • Anticipated CarbonSmart revenue did not materialize in 4Q 2023 due to availability of certified offtake supply to meet demand • 2023 Gross Margin improvement to 28% from 24% in 2022 due to favorable mix of high-margin services revenue • 2023 Adjusted EBITDA of $(80.1) million was below guidance • Despite miss to guidance, Adjusted EBITDA showed quarter-over-quarter improvement in 2023 mainly driven by focus on improving gross profit and operating expense control $37.3 $62.6 $80.0 $0 $20 $40 $60 $80 $100 2022 2023 2023 Guidance ($69.2) ($80.1) ($65.0) ($90) ($80) ($70) ($60) ($50) ($40) ($30) ($20) ($10) $0 2022 2023 2023 Guidance


 
6 THREE CORRECTIVE ACTIONS TAKEN IN RESPONSE TO 2023 PERFORMANCE HEADCOUNT REDUCTION MANAGEMENT TEAM REORGANIZATION 2023 LEADERSHIP BONUS REDUCTION


 
7 COST SAVINGS PLAN ENACTED DISCIPLINED FOCUS ON COST STRUCTURE • Enacted plan reducing workforce by approximately 5% • Workforce reduction expected to generate approximately $5.3 million of annualized operating expenses savings and $4.2 million of expected annualized cash savings • Plan to end 2024 with global headcount below 400 people • Have developed strategy ready for implementation that would offset an additional approximate $10 million in annual cash burn • As a result of 2023 financial performance objectives not being met, we reduced 2023 target cash bonus payments for executive and management teams by 80%, resulting in savings of approximately $3 million


 
8 EXECUTIVE TEAM REORGANIZATION SHARPEN AND ACCELERATE FOR GROWTH Aura Cuellar | President • All Revenue Business Lines • Strategic Projects • Engineering Dr. Robert Conrado | Chief Technology Officer • Technology Development up to Front End Engineering Design • Process Infrastructure Technology • Global IT & Scientific Computing DEPARTMENTAL CONSOLIDATATION UNDER NEW EXECUTIVE LEADERSHIP Dr. Zara Summers | Chief Science Officer • Research and Design • Synthetic and Systems Biology, Fermentation • Global Technology Deployment • Product Manufacturing


 
2023 MAJOR MILESTONES • 18+ years in operation • 3 commercial plant start-ups: • Total of 6 commercial plants operating that have a total installed nameplate capacity of 310,000 tonnes of ethanol annually • LanzaJet Freedom Pines Fuels facility mechanically complete with start up expected in 2024 9 SELECT RECOGNITION TIME100 MOST INFLUENTIAL COMPANIES LIST TIME100 CLIMATE LIST DELOITTE TECHNOLOGY FAST 500 AWARD ADIPEC DECARBONISATION AT SCALE AWARD TERRA CARTA SEAL AWARD FAST COMPANY’S WORLD’S MOST INNOVATIVE COMPANIES LIST


 
10 LANZAJET FREEDOM PINES FUELS INAUGURATION CEREMONY JANUARY 24, 2024


 
2024 STRATEGIC PRIORITIES Nasdaq: LNZA


 
12 2024 STRATEGIC PRIORITIES 1 2 3 SAFETY FIRST ▪ Zero recordable injuries ▪ Zero lost time injuries COMMERCIAL GROWTH ▪ Ramp up to full production at IndianOil and ArcelorMittal facilities ▪ Continued pipeline expansion and progression of projects through the development pipeline PATH TO PROFITABILITY ▪ Continued gross profit expansion, focused on strong-margin revenue opportunities ▪ Operating cost discipline


 
13 STRONG PIPELINE THAT POSITIONS THE COMPANY FOR CONTINUED GROWTH AND SCALE ACTIVE CUSTOMER BIOREFINING PROJECT PIPELINE1 1 Biorefining project pipeline as of February 15, 2024 Freedom Pines Fuels. Expected to begin operations and ramp up production in 2024 14% 42% 24% 15% 5% Gasified MSW Industrial Off Gas Other Gasified Solids CO2 + H2 Biogas ~79,000 tons Avg. Plant Capacity 25% 24%27% 17% 7% Asia & Pacific Americas Europe India Middle East PIPELINE BY FEEDSTOCKPIPELINE BY REGION KEY PIPELINE CHARACTERISTICS 60+ Active Engagements with Positive Technoeconomic Results 25+ Early-Stage Engineering 13 Advanced Engineering 1 Construction 8 Operating6 commercial projects: SGLT 1 – 4, IndianOil, and ArcelorMittal Gent 2 Demo-scale projects: Sekisui 1/10th plant and Suncor demo unit 2 projects advanced from early-stage engineering 5 net additions into this stage, advancing from TEA or directly entering phase Several projects into this phase


 
OVERVIEW OF 4Q 2023 AND FULL YEAR 2023 FINANCIAL RESULTS Nasdaq: LNZA


 
OVERVIEW OF 4Q AND FY 2023 FINANCIAL RESULTS 15 Summary Financial Results¹ Commentary Revenue: ▪ Revenue up 77% YoY in 4Q 2023, across all business lines. Biorefining revenue increased primarily from sales of engineering services indicating progression of projects through the pipeline. Gross Profit: ▪ Gross profit increase of 238% YoY and gross margin of 41% in 4Q 2023. Significant sequential improvement in gross margin reflective of strengthening revenue mix. Net Loss ▪ Net loss of $18.7 million in 4Q 2023, a $2.7 million improvement compared to 4Q 2022 driven by higher gross profit. Cash ▪ Total cash, investments, and restricted cash of $121.4 million. Cash burn reduced to $15.5 million in the fourth quarter. Three Months Ended December 31st Change Full Year Change (in millions) 2023 2022 2023 vs. 2022 2023 2022 2023 vs. 2022 Total Revenue $20.5 $11.6 $8.9 $62.6 $37.3 $25.3 Cost of Revenues 12.0 9.1 2.9 45.0 28.3 16.7 Operating Expenses 27.1 21.9 5.2 124.0 84.7 39.3 Net Loss $18.7 $21.4 $2.7 $134.1 $76.4 $(57.7) Adjusted EBITDA Loss $13.7 $17.1 $3.4 $80.1 $69.2 $(10.9) Dec. 2023 Sept. 2023 Change Total Cash and Investments $121.4 $136.9 $(15.5) 4Q and FY 2023 Disaggregated Revenue² ▪ Biorefining revenue increased by 103% YoY to $14.2 million in 4Q 2023 and by 101% YoY to $42.6 million in 2023 driven by increases in engineering and other services revenue as well as licensing revenue. ▪ CarbonSmart revenue increased 253% YoY to $2.1 million in 4Q 2023 and by 33% YoY to $5.3 million in 2023 from sales to multiple brand customers through commercial product campaigns. ▪ Joint Development & Contract Research revenue increased 5% YoY to $4.2 million in 4Q 2023 and by 21% YoY to $14.6 million in 2023, reflective of existing contract progression and new customer projects. $ millions Biorefining CarbonSmart Joint Development & Contract Research 1 Numbers may not add up due to rounding. 2 Numbers may not add up due to rounding. 4Q23 Biorefining revenue includes $1.5 million of related party revenue $4.0 $4.2 $12.1 $14.6 $0.6 $2.1 $4.0 $5.3 $7.0 $14.2 $21.2 $42.6 $0 $20 $40 $60 4Q 2022 4Q 2023 2022 2023 $11.6 $20.5 $62.6 $37.3


 
16 2024 GUIDANCE SUMMARY REVENUE GUIDANCE: $90M - $105M ▪ Expect growth across the business with strong quarterly growth throughout the year ▪ Anticipate revenue to be back-half weighted due to several projects expected to enter construction phase in the second half of 2024 ▪ Q1 2024 revenue expected to be similar to Q1 2023 revenue ADJUSTED EBITDA GUIDANCE: $(65)M - $(55)M ▪ Focus on high-quality margin opportunities and cost control


 
APPENDIX: ADDITIONAL FINANCIAL INFORMATION Nasdaq: LNZA


 
18 RESULT OF OPERATIONS – FULL-YEAR ENDED DECEMBER 31, 2023


 
19 RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA


 
APPENDIX: EXECUTIVE TEAM BIOGRAPHIES OF PROMOTED INDIVIDUALS Nasdaq: LNZA


 
21 EXECUTIVE TEAM BIOGRAPHIES OF PROMOTED INDIVIDUALS From environmental engineer to senior business leader, Aura Cuellar is determined to lead the energy industry on a path to profitable decarbonization. As LanzaTech’s President, Aura brings to her role extensive experience in manufacturing and a successful track record in global strategy development and implementation. Her time living and working in Europe, Africa, Asia and North and South America has shaped her inclusive world view and deep appreciation for regional approaches to address climate change and deliver growth. Prior to joining LanzaTech, Aura served as Vice President of Energy Transition for Shell in the United States. In her 25-year tenure at Shell, she advanced across various global senior executive roles including Head of Projects and Turnarounds in The Netherlands and being responsible for an annual capital projects portfolio of $500 million. Aura’s leadership was forged in manufacturing assets, including P&L responsibility and strategic commercial partnership development for sustainable revenue pipelines. Aura is passionate about cultural transformation with a focus on innovation and social equity. She excels in building integrated, robust teams in which individuals are empowered to deliver impactful commercial results. Aura also serves as Honorary Consul to the Kingdom of The Netherlands in Houston, a role in which she contributes to addressing the shared challenges of climate adaptation and resilience, health and vitality, sustainable mobility, and the energy transition. Originally from Colombia, Aura holds a bachelor’s degree in Environmental and Civil Engineering from Seattle University, an MBA from Western Washington University, and completed Executive General Management from INSEAD and Harvard’s Women on Boards Program. Aura Cuellar | President • All Revenue Business Lines • Strategic Projects • Engineering


 
22 EXECUTIVE TEAM BIOGRAPHIES OF PROMOTED INDIVIDUALS Dr. Zara Summers | Chief Science Officer • Research and Design • Synthetic and Systems Biology, Fermentation • Global Technology Deployment • Product Manufacturing Dr. Zara Summers is currently the Chief Science Officer at LanzaTech. She spent almost 10 years at ExxonMobil where she held a variety of scientific and leadership positions, all focused on helping to provide biological solutions for navigating the energy transition. Most recently, Zara worked to drive the development of a corporate research strategy on Nature Based Solutions and worked to understand the impacts of subsurface microorganisms on underground CO2 sequestration. Throughout her career, Zara has been most energized by working to identify solutions to enhance economic, environmental, and climate stability. At LanzaTech, Zara leads the passionate and innovative Science team, combining biology and engineering to tackle carbon transformation. The Science team works to provide solutions to address society’s challenge of mitigating climate change while providing the world the energy and products required to not only survive, but thrive. Zara holds a Ph.D. in Microbiology from the University of Massachusetts and competed her postdoctoral work at the University of Minnesota.


 
23 EXECUTIVE TEAM BIOGRAPHIES OF PROMOTED INDIVIDUALS Dr. Robert Conrado | Chief Technology Officer • Technology Development up to Front End Engineering Design • Process Infrastructure Technology • Global IT & Scientific Computing Dr. Robert Conrado is LanzaTech’s Chief Technology Officer and previously served as LanzaTech’s Executive Vice President of Engineering Design and Development since September 2023. Robert has held various engineering leadership roles at LanzaTech since joining the company in 2013, serving as Vice President of Engineering Design and Development from October 2018 to September 2023, Director of Engineering Design and Development from 2016 to October 2018, and Manager of Engineering Design and Development from 2015 to 2016. Prior to his tenure at LanzaTech, Robert was a founding Senior Fellow at the Advanced Research Projects Agency — Energy (ARPA-E) within the U.S. Department of Energy. Robert holds a Ph.D. from Cornell University in Chemical and Biomolecular Engineering, and a B.E. from Dartmouth College in Biochemical Engineering.


 
FINANCIAL INFORMATION & NON-GAAP FINANCIAL MEASURES 24 To supplement our financial statements presented in accordance with US GAAP and to provide investors with additional information regarding our financial results, we have presented adjusted EBITDA, a non- GAAP financial measure. Adjusted EBITDA is not based on any standardized methodology prescribed by US GAAP and is not necessarily comparable to similarly titled measures presented by other companies. We define adjusted EBITDA as our net loss, excluding the impact of depreciation, interest income, net, stock-based compensation, change in fair value of warrant liabilities, change in fair value of SAFE liabilities, change in fair value of the prepaid forward contract derivative and Fixed Maturity Consideration, transaction costs on issuance of Forward Purchase Agreement, (gain) loss from equity method investees and other one-time costs related to the Business Combination and initial securities registration. We monitor and have presented in this Quarterly Report adjusted EBITDA because it is a key measure used by our management and the Board to understand and evaluate our operating performance, to establish budgets, and to develop operational goals for managing our business. We believe adjusted EBITDA helps identify underlying trends in our business that could otherwise be masked by the effect of certain expenses that we include in net loss. Accordingly, we believe adjusted EBITDA provides useful information to investors, analysts, and others in understanding and evaluating our operating results and enhancing the overall understanding of our past performance and future prospects. Adjusted EBITDA is not prepared in accordance with US GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with US GAAP. There are a number of limitations related to the use of adjusted EBITDA rather than net loss, which is the most directly comparable financial measure calculated and presented in accordance with US GAAP. For example, adjusted EBITDA: (i) excludes stock-based compensation expense because it is a significant non-cash expense that is not directly related to our operating performance; (ii) excludes depreciation expense and, although this is a non-cash expense, the assets being depreciated and amortized may have to be replaced in the future; (iii) excludes gain or losses on equity method investee; and (iv) excludes certain income or expense items that do not provide a comparable measure of our business performance. In addition, the expenses and other items that we exclude in our calculations of adjusted EBITDA may differ from the expenses and other items, if any, that other companies may exclude from adjusted EBITDA when they report their operating results. In addition, other companies may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.